Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab).

Pediatrics

Volumn 108, Issue 2, 2001, Pages

  Milgrom, H ^a   Berger, W ^a   Nayak, A ^a   Gupta, N ^a   Pollard, S ^a   McAlary, M ^a   Taylor, A F ^a   Rohane, P ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIALLERGIC AGENT; ANTIASTHMATIC AGENT; BECLOMETASONE; MONOCLONAL ANTIBODY; OMALIZUMAB; PLACEBO;

ACUTE DISEASE; ARTICLE; ASTHMA; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG COMBINATION; FEMALE; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

ACUTE DISEASE; ANTI-ALLERGIC AGENTS; ANTI-ASTHMATIC AGENTS; ANTIBODIES, MONOCLONAL; ASTHMA; BECLOMETHASONE; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; PLACEBOS; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 0035434688     PISSN: None     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.108.2.e36     Document Type: Article

References (0)